Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paweł Żebrowski

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Wiadomosci Lekarskie (Warsaw, Poland : 1960)|March 19, 2015
[The integrated renal replacement therapy]Ewa Wojtaszek, Paweł Żebrowski
Wiadomosci Lekarskie (Warsaw, Poland : 1960)|December 21, 2019
[Ezetimibe as a treatment for dyslipidaemia in CKD]Paweł Żebrowski, Maria Kaszyńska
Wiadomosci Lekarskie (Warsaw, Poland : 1960)|May 11, 2016
[Age-related kidney problems]Paweł Żebrowski, Paweł Kulicki
Wiadomosci Lekarskie (Warsaw, Poland : 1960)|May 11, 2016
[Acute kidney injury in liver transplantation]Małgorzata Kościelska, Paweł Żebrowski
Wiadomosci Lekarskie (Warsaw, Poland : 1960)|December 30, 2016
[Erythropoietin stimulating agents in chronic kidney disease: indications and contraindications]Paweł Żebrowski, Mariusz Mieczkowski
Wiadomosci Lekarskie (Warsaw, Poland : 1960)|December 30, 2016
[Paricalcitol - a selective vitamin D receptor activator for secondary hyperparathyroidism in patients with chronic kidney disease]Joanna Matuszkiewicz-Rowińska, Paweł Żebrowski
Wiadomosci Lekarskie (Warsaw, Poland : 1960)|December 21, 2019
[The role of slow low efficiency dialysis (sled) in renal replacement therapy]Małgorzata Kościelska, Paweł Żebrowski, Jolanta Małyszko
Transplantation Proceedings|May 5, 2020
Malignancy Prevalence in Waitlisted Potential Kidney Transplant Recipients Is Very Low Relative to Patients After Kidney TransplantationMichał Pyrża, Jacek Małyszko, Paweł Żebrowski, et al.
Renal Failure|June 13, 2020
Medical waste management - how industry can help us to protect environment and money?Paweł Żebrowski, Jacek Zawierucha, Tomasz Prystacki, et al.
Przeglad Lekarski|April 29, 2016
[Brief measure to assess patient perception of self-influence on the disease course-version for hemodialysis]Wojciech M Orzechowski, Bartosz Fiderkiewicz, Paweł Żebrowski, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Wiadomosci Lekarskie (Warsaw, Poland : 1960)|March 19, 2015
[The integrated renal replacement therapy]Ewa Wojtaszek, Paweł Żebrowski
Wiadomosci Lekarskie (Warsaw, Poland : 1960)|December 21, 2019
[Ezetimibe as a treatment for dyslipidaemia in CKD]Paweł Żebrowski, Maria Kaszyńska
Wiadomosci Lekarskie (Warsaw, Poland : 1960)|May 11, 2016
[Age-related kidney problems]Paweł Żebrowski, Paweł Kulicki
Wiadomosci Lekarskie (Warsaw, Poland : 1960)|May 11, 2016
[Acute kidney injury in liver transplantation]Małgorzata Kościelska, Paweł Żebrowski
Wiadomosci Lekarskie (Warsaw, Poland : 1960)|December 30, 2016
[Erythropoietin stimulating agents in chronic kidney disease: indications and contraindications]Paweł Żebrowski, Mariusz Mieczkowski
Wiadomosci Lekarskie (Warsaw, Poland : 1960)|December 30, 2016
[Paricalcitol - a selective vitamin D receptor activator for secondary hyperparathyroidism in patients with chronic kidney disease]Joanna Matuszkiewicz-Rowińska, Paweł Żebrowski
Wiadomosci Lekarskie (Warsaw, Poland : 1960)|December 21, 2019
[The role of slow low efficiency dialysis (sled) in renal replacement therapy]Małgorzata Kościelska, Paweł Żebrowski, Jolanta Małyszko
Transplantation Proceedings|May 5, 2020
Malignancy Prevalence in Waitlisted Potential Kidney Transplant Recipients Is Very Low Relative to Patients After Kidney TransplantationMichał Pyrża, Jacek Małyszko, Paweł Żebrowski, et al.
Renal Failure|June 13, 2020
Medical waste management - how industry can help us to protect environment and money?Paweł Żebrowski, Jacek Zawierucha, Tomasz Prystacki, et al.
Przeglad Lekarski|April 29, 2016
[Brief measure to assess patient perception of self-influence on the disease course-version for hemodialysis]Wojciech M Orzechowski, Bartosz Fiderkiewicz, Paweł Żebrowski, et al.
Pageof 3